Lineage Cell Therapeutics Revenue

Biotechnology Research • Carlsbad, California, United States • 21-50 Employees

Lineage Cell Therapeutics revenue & valuation

Annual revenue	$11,000,000
Revenue per employee	$342,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$35,000,000
Total funding	$42,000,000

Key Contacts at Lineage Cell Therapeutics

Brian Culley

Chief Executive Officer Of Lineage Cell Therapeutics, Inc. Nyse:Lctx

Cheryl Liberatore

Sr. Director, Human Resources & Infrastructure

Michael Mulroy

Member Of The Board Of Directors

Nina Orike

Director

Company overview

Headquarters	2173 Salk Avenue, Suite 200, Carlsbad, CA 92008, US
Phone number	+14422878990
Website	lineagecell.com
NAICS	541714
SIC	873
Founded	1990
Employees	21-50
Socials

Lineage Cell Therapeutics Email Formats

Lineage Cell Therapeutics uses 3 email formats. The most common is {first initial}{last name} (e.g., jdoe@lineagecell.com), used 85% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@lineagecell.com	85%
{first name}{last name}	johndoe@lineagecell.com	10%
{first name}	john@lineagecell.com	5%

About Lineage Cell Therapeutics

Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its proprietary cell-based therapy platform and associated development and manufacturing capabilities. With this platform Lineage develops and manufactures specialized, terminally-differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed either to replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Lineage’s clinical assets include (i) OpRegen®, a retinal pigment epithelium transplant therapy in Phase I/IIa development for the treatment of dry age-related macular degeneration, a leading cause of blindness in the developed world; (ii) OPC1, an oligodendrocyte progenitor cell therapy in Phase I/IIa development for the treatment of acute spinal cord injuries; and (iii) VAC2, an allogeneic cancer immunotherapy of antigen-presenting dendritic cells currently in Phase I development for the treatment of non-small cell lung cancer. For more information, please visit www.lineagecell.com.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Manager

Vice President

Employees by Department

Lineage Cell Therapeutics has 15 employees across 9 departments.

Departments

Number of employees

Funding Data

Explore Lineage Cell Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2024-12-20	14	$30,000,000
2025-09-26	9	$12,000,000

Funding Insights

$42,000,000

Total funding amount

$12,000,000

Most recent funding amount

Number of funding rounds

Lineage Cell Therapeutics Tech Stack

Discover the technologies and tools that power Lineage Cell Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Cloudflare

CDN

MediaElement.js

Video players

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

Google Tag Manager

Tag managers

HTTP/3

Miscellaneous

PHP

Programming languages

Open Graph

Miscellaneous

WordPress

Blogs

jQuery Migrate

JavaScript libraries

Google Analytics

Analytics

YouTube

Video players

Frequently asked questions

Lineage Cell Therapeutics is located in Carlsbad, California, US.

You can reach Lineage Cell Therapeutics at +14422878990.

Lineage Cell Therapeutics generates an estimated annual revenue of $10,914,000. This revenue figure reflects the company's market position and business performance in its industry.

Lineage Cell Therapeutics has an estimated valuation of $35,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Lineage Cell Therapeutics was founded in 1990, making it 36 years old. The company has established itself as a significant player in its industry over this time.

Lineage Cell Therapeutics has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Lineage Cell Therapeutics has raised a total of $42,000,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.